Characteristics of 16 patients treated for intracranial atherosclerotic disease
| Pt/Age (y)/Sex | Stenotic Portion | Stenotic Rate (%) | Lesion Length (mm) | Antiplatelet Therapy | Endovascular Therapy | Device* | Anticoagulation (d) | DWI† | ||
|---|---|---|---|---|---|---|---|---|---|---|
| Before | After | Abnormality | Location | |||||||
| 1/58/M | L C4 stenosis | 70 | 0 | 9 | 31 d | PTA, stenting | Savvy 3.0 × 20, S670 4.0 × 12 | 3 | A | Not applicable |
| 2/58/M | R C4 stenosis | 85 | 0 | 20 | 10 d | PTA, stenting | Maverick 2.5 × 20, S670 3.0 × 24 | 1 | C | Frontal, parietal |
| 3/68/M | R C4 stenosis | 76 | 0 | 12 | 60 d | PTA, stenting | Gateway 3.0 × 15, Bx-Velocity 4.5 × 18 | 2 | C | Frontal, parietal, basal ganglia |
| 4/70/F | R C4 stenosis | 63 | 15 | 7 | 30 d | PTA, stenting | Open sail 2.5 × 10, S670 3.5 × 9 | 3 | B | Frontal (contralateral) |
| 5/71/M | R C5 stenosis | 67 | 0 | 13 | 19 d | PTA, stenting | Maverick 3.5 × 15, S670 3.5 × 15 | 1 | B | Frontal |
| 6/78/M | R C5 stenosis | 60 | 0 | 7 | 13 d | Primary stenting | S670 3.5 × 15 | 1 | B | Frontal (contralateral) |
| 7/59/M | R C5 stenosis | 70 | 0 | 10 | 27 d | PTA, stenting | Gateway 3.0 × 15, Bx-Velocity 3.5 × 13 | 1 | B | Frontal |
| 8/62/M | R C5 stenosis | 60 | 10 | 6 | 19 d | Primary stenting | NIR 4.0 × 9.0 | 5 | A | Not applicable |
| 9/74/M | R C5 stenosis | 68 | 0 | 15 | 26 d | PTA, stenting | Gateway 3.5 × 9.0, Bx-Velocity 4.5 × 18 | 1 | C | Frontal, basal ganglia |
| 10/76/M | L C4 stenosis | 60 | 0 | 9 | 9 y | Primary stenting | S670 4.0 × 12.0 | 1 | A | Not applicable |
| 11/76/M | ||||||||||
| Procedure 1 | R M1 stenosis | 70 | 40 | 7 | 7 d | PTA | Gateway 2.0 × 12, 2.5 × 12 | 1 | A | Not applicable |
| Procedure 2 | R M1 restenosis | 60 | 10 | 7 | 96 d | PTA | Gateway 2.5 × 12 | 1 | B | Parietal |
| 12/68/M | L M1 restenosis | 67 | 10 | 9 | 1 y | PTA | Ranger 1.5 × 20, 2.0 × 20 | 1 | A | Not applicable |
| 13/65/M | R M1 stenosis | 80 | 20 | 7 | 29 d | PTA | Fas stealth 2.0 × 10 | 5 | A | Not applicable |
| 14/64/F | R M1 stenosis | 70 | 30 | 6 | 41 d | PTA | Ranger 2.0 × 20, 2.5 × 20 | 1 | A | Not applicable |
| 15/56/M | L M1-2 stenosis | 80 | 20 | 4 | 9 d | PTA | Fas stealth 2.0 × 10 | 2 | A | Not applicable |
| 16/77/M | L M1 stenosis | 80 | 40 | 6 | 11 d | PTA | Gateway 2.0 × 12 | 1 | A | Not applicable |
Note.—No new deficits were observed.
* Dimensions are in millimeters.
† Type A is no hyperintensities; type B, a single lesion; and type C, multiple lesions.